SubbaRao V Tulimilli

7PUBLICATIONS
17CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersIntensive careNanophotonics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 28, 2026
An Overview of the Mechanisms of HPV-Induced Cervical Cancer: The Role of Kinase Targets in Pathogenesis and Drug Resistance.

Medha Karnik, SubbaRao V Tulimilli, Preethi G Anantharaju

|Sep 08, 2025
Vitamin D3 reduces the viability of cancer cells in vitro and retard the EAC tumors growth in mice.

Vidya G Bettada, Chaithanya G Basavaraju, Shalini H Doreswamy

|Sep 28, 2024
Vitamin D in Cancer Prevention and Treatment: A Review of Epidemiological, Preclinical, and Cellular Studies.

Siva Dallavalasa, SubbaRao V Tulimilli, Vidya G Bettada

|Jul 26, 2024
SARS-CoV-2 Infection Positively Correlates with Hyperglycemia and Inflammatory Markers in COVID-19 Patients: A Clinical Research Study.

Prashanth Chikkahonnaiah, Siva Dallavalasa, SubbaRao V Tulimilli

|Jun 28, 2023
Folate targeting self-limiting hyperthermic nanoparticles for controlled photothermal therapy.

Sharon George, Asha Srinivasan, SubbaRao V Tulimilli

|Feb 25, 2023
COVID-19: Diabetes Perspective-Pathophysiology and Management.

Siva Dallavalasa, SubbaRao V Tulimilli, Janhavi Prakash

Pageof 2

Frequent Collaborators

7 joint publications

SubbaRao V Madhunapantula

2 joint publications

Medha Karnik

2 joint publications

Ravindra P Veeranna

1 joint publications

Narasimha M Beeraka